Triochem Products returns to Rs 8.40 lakh quarterly profit

Triochem Products Limited reported net profit of Rs 8.40 lakh for the quarter ended 30 September 2026, reversing a Rs 19.26 lakh loss a year earlier. Total income from operations was Rs 16.72 lakh, while total expenses declined to Rs 5.82 lakh from Rs 44.13 lakh in the September 2025 quarter.

How did Triochem Products perform in the September 2026 quarter?

Triochem Products returned to profit in the September 2026 quarter, recording profit after tax of Rs 8.40 lakh compared with a Rs 19.26 lakh loss in the quarter ended 30 September 2025. Profit before tax was Rs 10.90 lakh, compared with a pre-tax loss of Rs 14.61 lakh a year earlier, while total income from operations was Rs 16.72 lakh.

Profit after tax was below the Rs 9.48 lakh reported in the preceding quarter ended 30 June 2026. Total income increased slightly from Rs 16.56 lakh in June, but total expenses rose to Rs 5.82 lakh from Rs 4.17 lakh, reducing pre-tax profit from Rs 12.39 lakh to Rs 10.90 lakh.

The year-on-year return to profit coincided with expenses falling by Rs 38.31 lakh, more than the Rs 12.80 lakh reduction in income. Triochem Products operates in a single chemicals and pharmaceuticals segment, so the filing does not provide separate revenue or profit figures for either activity.

What do the half-year results show for Triochem Products?

Triochem Products reported profit after tax of Rs 17.88 lakh for the half year ended 30 September 2026, compared with a Rs 22.32 lakh loss in the corresponding 2025 period. Pre-tax profit was Rs 23.29 lakh against a Rs 29.85 lakh pre-tax loss, while total income rose to Rs 33.28 lakh from Rs 31.62 lakh.

Expenses for the six months declined to Rs 9.99 lakh from Rs 81.47 lakh in the previous-year half. Tax expense was Rs 5.41 lakh, including Rs 4.80 lakh of current tax and Rs 61,000 of deferred tax, and basic as well as diluted earnings per share, not annualised, were Rs 7.30 against a loss per share of Rs 9.11.

Total comprehensive income, which includes items recorded outside profit or loss, was Rs 53.92 lakh for the first half of 2026-27, compared with Rs 42.25 lakh a year earlier. In the September quarter, total comprehensive income was a negative Rs 41.62 lakh despite net profit of Rs 8.40 lakh, whereas the June quarter recorded Rs 95.54 lakh.

What does Triochem Products' balance sheet show?

Triochem Products had total assets of Rs 21.91 crore at 30 September 2026, compared with Rs 20.88 crore at 31 March 2026. Shareholders’ funds increased to Rs 21.37 crore from Rs 20.65 crore, with other equity rising to Rs 21.12 crore from Rs 20.40 crore and equity share capital unchanged at Rs 24.50 lakh.

Non-current investments rose to Rs 8.79 crore at 30 September from Rs 7.89 crore at 31 March. Cash and cash equivalents were Rs 11.70 crore, compared with Rs 11.73 crore at the financial year-end, while other current assets increased to Rs 1.28 crore from Rs 1.25 crore and other tax assets rose to Rs 13.41 lakh from Rs 33,000.

Total liabilities were Rs 54.26 lakh at 30 September 2026, compared with Rs 23.06 lakh at 31 March 2026. Deferred tax liabilities accounted for Rs 52.62 lakh, up from Rs 19.94 lakh, while current financial liabilities were Rs 1.60 lakh and other current liabilities were Rs 4,000.

What happened to Triochem Products' cash and investments?

Triochem Products' cash and cash equivalents declined by Rs 2.59 lakh during the half year ended 30 September 2026, closing at Rs 11.70 crore from an opening balance of Rs 11.73 crore. Net cash used in operating activities was Rs 17.90 lakh, compared with Rs 47.25 lakh used in the corresponding half year of 2025.

The cash-flow statement reported Rs 29 lakh of net cash from investing activities in the six months to September 2026, compared with Rs 8.84 lakh a year earlier. Dividend income from investments was Rs 29.02 lakh, against Rs 8.52 lakh in the prior-year period, while non-current investments increased by Rs 90.26 lakh between 31 March and 30 September.

Current liabilities totalled Rs 1.64 lakh at 30 September 2026, compared with cash and cash equivalents of Rs 11.70 crore. The board approved the unaudited standalone results on 4 November 2026 after audit committee review, and the statutory auditors issued an unqualified conclusion on the results.

How does the earlier asset sale affect comparison with Triochem Products' results?

Triochem Products disclosed that the previous period included an exceptional gain of Rs 11.17 crore from asset sales, affecting comparison with the year ended 31 March 2026. Net profit after tax for that year was Rs 7.97 crore, while the sold assets had an aggregate written-down value of Rs 56.92 lakh.

An independent registered valuer determined fair market value of about Rs 6.72 crore for property, plant and machinery and Rs 5.01 crore for investment properties, net of Rs 8.85 lakh of transfer expenses. Triochem Products said the sale consideration was received entirely in cash and the arm’s-length transaction monetised non-core assets.

Management said the proceeds are proposed for new business ventures and other strategic initiatives. The filing does not quantify the planned deployment, identify the ventures or set an execution timetable, and the September 2026 quarterly profit of Rs 8.40 lakh contained no exceptional item.

Conclusion

Triochem Products moved from a Rs 19.26 lakh quarterly loss in September 2025 to an Rs 8.40 lakh profit in September 2026, while half-year profit reached Rs 17.88 lakh against a Rs 22.32 lakh loss. The comparison reflects a lower expense base, with quarterly expenses falling to Rs 5.82 lakh from Rs 44.13 lakh despite income declining to Rs 16.72 lakh.

The next point to watch is management’s disclosed proposal to use the prior asset-sale proceeds, including the Rs 11.17 crore exceptional gain, for new business ventures and strategic initiatives. The filing provides no investment amount, timetable or operating target for that plan, while cash and cash equivalents stood at Rs 11.70 crore on 30 September 2026.